Study of Oral MRT-2359 in Selected Cancer Patients
Monte Rosa Therapeutics, Inc
Monte Rosa Therapeutics, Inc
Essen Biotech
M.D. Anderson Cancer Center
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Intensity Therapeutics, Inc.
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Icahn School of Medicine at Mount Sinai
Cellestia Biotech AG
Ludwig Institute for Cancer Research
Shenzhen Geno-Immune Medical Institute
Incyte Corporation
University of Kentucky
Northwestern University
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center